- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04247685
Evaluation of MRI-conditional 12-lead ECG
October 31, 2022 updated by: Dr. Graham Wright
With MRI's increasing role in detecting central nervous system and orthopedic diseases, patients with ischemic history are increasingly referred for MRI exams.
Currently, 3-lead ECG gating systems are utilized during cardiac MRI scanning as standard of care.
However, this monitoring system is often insufficient to evaluate for the development of important arrhythmias or ischemia during MRI scanning.
Morevoer, MRI associated magnetic fields and radio frequency pulses can produce interference in the ECG signal that leads to non-diagnostic ECG signals.
MiRTLE Medical, a Massachusetts-based medical device company, has developed a high-fidelity, MRI-conditional 12-lead ECG monitoring system.
This 12-lead ECG system is a first of its kind that addresses the MRI-induced interference and safety issues.
This study is to evaluate the efficacy of this 12-lead ECG system in the clinical setting.
The investigators hope that this system will be helpful for image-guided therapeutics especially electrophysiology.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mary Li, MSc
- Phone Number: 89664 4164806100
- Email: mary.li@sunnybrook.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- Recruiting
- Sunnybrook Health Sciences Center
-
Contact:
- Mary Li
- Phone Number: 89664 4164806100
- Email: mary.li@sunnybrook.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age and older
- Atrial fibrillation
- Provision of informed consent
- Eligible for the Ontario Health Insurance Plan
Exclusion Criteria:
- Failure to provide informed consent
- Pregnant women
- CMR contra-indicated
- Hemodynamically unstable
- Permanent pacemaker/ICD
- Aneurysm clip/carotid artery vascular clamp
- Claustrophobic
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 12-Lead ECG
The study group patients will have MRI with 12-lead ECG monitoring device produced by a Massachusetts-based medical device company MiRTLE Medical
|
12-lead ECG monitoring device produced by a Massachusetts-based medical device company MiRTLE Medical is the experimental device;
|
Active Comparator: 3-lead ECG gating system
the control group will have MRI with 3-lead ECG gating which is standard of care.
|
3-lead ECG gating system is the placebo/standard of care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
absolute numbers and percentages
Time Frame: up to 6 weeks
|
the following patient data will be collected as absolute numbers and percentages in a future Table 1: Age, Sex, Cardiovascular Risk Factors (DM, HTN, Dyslipidemia, smoking, family history of cardiovascular disease), Atrial fibrillation risk factors (CHADS-2 score; CHF, Age >75, DM, prior stroke/CVA), Prior atrial fibrillation ablation procedures, echocardiographic parameters (LVEF, Left atrial size), MRI parameters (Left ventricular end-diastolic volume, left ventricular end systolic volume, left ventricular stroke volume, LVEF, left atrial volume, right ventricular volumes and ejection fraction.)
|
up to 6 weeks
|
qualitatively comparison with a standard scale
Time Frame: up to 6 weeks
|
qualitatively comparison will be done for ECG signal quality and artifact between the 12-lead and 3-lead ECG arms using a standard scale. A 5 point Likert scale will be used with the below scores:
|
up to 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 18, 2021
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
December 1, 2024
Study Registration Dates
First Submitted
October 28, 2019
First Submitted That Met QC Criteria
January 29, 2020
First Posted (Actual)
January 30, 2020
Study Record Updates
Last Update Posted (Actual)
November 2, 2022
Last Update Submitted That Met QC Criteria
October 31, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 314-2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrial Fibrillation
-
Ablacon, Inc.CompletedArrhythmias, Cardiac | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Longstanding Persistent Atrial FibrillationGermany
-
Ablacon, Inc.RecruitingAtrial Fibrillation | Arrhythmias, Cardiac | Arrhythmia | Atrial Flutter | Atrial Fibrillation, Persistent | Atrial Tachycardia | Atrial Arrhythmia | Atrial Fibrillation Paroxysmal | Atrial Fibrillation, Paroxysmal or PersistentUnited States, Belgium, Netherlands, Czechia
-
Barts & The London NHS TrustAtriCure, Inc.Not yet recruitingAtrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial Arrhythmia | Atrium; FibrillationUnited Kingdom
-
AtriCure, Inc.Active, not recruitingPersistent Atrial Fibrillation | Atrial Fibrillation (AF) | Longstanding Persistent Atrial FibrillationUnited States
-
Maastricht University Medical CenterRWTH Aachen UniversityUnknownAtrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene VariantsNetherlands
-
Adagio MedicalRecruitingAtrial Fibrillation | Atrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationNetherlands, Germany, Belgium
-
Vivek ReddyEnrolling by invitationAtrial Fibrillation and Flutter | Atrial Flutter Typical | Atrial Fibrillation, Paroxysmal or PersistentUnited States
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingAtrial Arrhythmia | Atrial Fibrillation and Flutter | Atrial Fibrillation RecurrentSpain
-
St. George's Hospital, LondonRecruitingAtrial Fibrillation | Atrial Fibrillation, Persistent | Persistent Atrial Fibrillation | Atrial ArrhythmiaUnited Kingdom
-
R-PharmFSBI "National Medical Research Center of Cardiology named after academician...CompletedAtrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial FibrillationRussian Federation
Clinical Trials on 12-lead ECG monitoring device (MiRTLE Medical)
-
The Leeds Teaching Hospitals NHS TrustLeeds and York Partnership NHS Foundation TrustUnknownCardiovascular Diseases | Dementia | Mental Health DisorderUnited Kingdom
-
Apple Inc.Iqvia Pty LtdCompleted
-
Apple Inc.Iqvia Pty LtdCompleted
-
Huawei Device Co., LtdCompletedArrhythmias, CardiacChina
-
Murdoch Childrens Research InstituteRecruiting
-
Mayo ClinicNot yet recruitingHypertrophic Cardiomyopathy | Athlete HeartUnited States
-
University Hospital, BordeauxRecruitingVentricular ArrhythmiasFrance
-
AliveCorRecruitingMyocardial Infarction | Ischemia | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Heart Failure | Heart AttackUnited States
-
Qompium NVCompleted
-
Royal Cornwall Hospitals TrustTerminatedCoronary Artery Disease | Diastolic DysfunctionUnited Kingdom